AI assistant
Sending…
Nykode Therapeutics ASA — Director's Dealing 2023
Oct 25, 2023
3695_dirs_2023-10-25_876206cb-f430-41f6-9723-8596263b6ede.pdf
Director's Dealing
Open in viewerOpens in your device viewer
| 1 | Details of the person discharging managerial responsibilities/person closely associated |
||
|---|---|---|---|
| a) | Name | Datum AS | |
| 2 | Reason for the notification | ||
| a) | Position/status | Person closely associated with Harald Arnet, board member of the issuer |
|
| b) | Initial Notification / Amendment |
Initial | |
| 3 | Details of the issuer | ||
| a) | Name | Nykode Therapeutics ASA |
|
| b) | LEI | 254900UKQHWYZJD22017 | |
| 4 | Details of the transaction: | ||
| a) | Description of the financial instrument, type of instrument Identification code |
Shares in Nykode Therapeutics ASA, with ISIN NO0010714785 | |
| b) | Nature of the transaction |
Acquisition of shares | |
| c) | Price(s) and volume(s) |
||
| Price (s) |
Volume (s) |
||
| NOK 17.82 | 500,000 | ||
| d) | Aggregated information — Aggregated volume — Price |
||
| Price | Volume(s) | ||
| NOK 8,910,000 | 500,000 | ||
| e) | Date of the transaction |
2023-10-25 | |
| f) | Place of the transaction |
The Oslo Stock Exchange |
More from Nykode Therapeutics ASA
Interim / Quarterly Report
2026
May 27
Earnings Release
2026
May 27
Report Publication Announcement
2026
May 18
Report Publication Announcement
2026
May 18
Declaration of Voting Results & Voting Rights Announcements
2026
May 13
Report Publication Announcement
2026
May 13
Regulatory Filings
2026
May 7
Capital/Financing Update
2026
May 7
Investor Presentation
2026
Apr 30
Investor Presentation
2026
Apr 30